CAZZANIGA, MASSIMO
 Distribuzione geografica
Continente #
EU - Europa 3.330
NA - Nord America 2.136
AS - Asia 1.916
SA - Sud America 237
AF - Africa 47
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.676
Nazione #
US - Stati Uniti d'America 2.067
GB - Regno Unito 1.344
SG - Singapore 693
CN - Cina 641
IT - Italia 428
DE - Germania 404
SE - Svezia 236
RU - Federazione Russa 216
UA - Ucraina 205
BR - Brasile 147
NL - Olanda 139
TR - Turchia 124
IN - India 123
IE - Irlanda 121
HK - Hong Kong 117
KR - Corea 113
EU - Europa 99
FR - Francia 76
FI - Finlandia 65
CO - Colombia 56
CA - Canada 43
GR - Grecia 34
VN - Vietnam 31
CI - Costa d'Avorio 20
BD - Bangladesh 12
IQ - Iraq 12
MX - Messico 12
ID - Indonesia 11
JP - Giappone 10
BE - Belgio 9
ES - Italia 9
AR - Argentina 8
EC - Ecuador 7
RO - Romania 7
DK - Danimarca 6
PE - Perù 6
CL - Cile 5
CZ - Repubblica Ceca 5
EG - Egitto 5
LT - Lituania 5
PK - Pakistan 5
AT - Austria 4
AU - Australia 4
MA - Marocco 4
VE - Venezuela 4
ZA - Sudafrica 4
NP - Nepal 3
PT - Portogallo 3
SA - Arabia Saudita 3
TH - Thailandia 3
AE - Emirati Arabi Uniti 2
BY - Bielorussia 2
CR - Costa Rica 2
ET - Etiopia 2
IR - Iran 2
JM - Giamaica 2
LU - Lussemburgo 2
NZ - Nuova Zelanda 2
PA - Panama 2
PH - Filippine 2
PL - Polonia 2
SD - Sudan 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AZ - Azerbaigian 1
BB - Barbados 1
BO - Bolivia 1
CG - Congo 1
CH - Svizzera 1
CU - Cuba 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
GF - Guiana Francese 1
GP - Guadalupe 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IS - Islanda 1
JO - Giordania 1
KE - Kenya 1
KW - Kuwait 1
KZ - Kazakistan 1
LC - Santa Lucia 1
LK - Sri Lanka 1
ME - Montenegro 1
MK - Macedonia 1
MW - Malawi 1
MY - Malesia 1
NC - Nuova Caledonia 1
NG - Nigeria 1
PY - Paraguay 1
RW - Ruanda 1
SN - Senegal 1
SR - Suriname 1
TN - Tunisia 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 7.771
Città #
Southend 1.263
Singapore 310
Ashburn 198
Jacksonville 184
Chandler 172
Beijing 160
Princeton 143
Seattle 126
Dublin 118
Santa Clara 117
Hong Kong 116
Wilmington 97
Bengaluru 85
Milan 84
Redmond 78
Mountain View 75
Nanjing 75
Frankfurt am Main 73
Council Bluffs 70
Serra 66
Bogotá 54
Sakarya 54
Andover 52
Ann Arbor 47
Dallas 42
Los Angeles 42
Somerville 40
Toronto 36
Athens 34
Munich 34
Buffalo 33
Boardman 29
Dearborn 27
Nanchang 27
Shanghai 27
Des Moines 25
Hefei 25
Rome 24
Moscow 23
Kiez 22
Abidjan 20
Houston 20
Cangzhou 19
Tianjin 19
Bitonto 18
São Paulo 18
Woodbridge 18
Guangzhou 17
Hebei 17
The Dalles 16
Düsseldorf 15
Pisa 15
Fairfield 14
Grafing 14
Ho Chi Minh City 14
Shenyang 14
Berlin 13
Columbus 13
Eitensheim 12
Fremont 12
Hamburg 12
Changsha 10
Jinan 10
Palermo 10
San Jose 10
Tokyo 10
Verona 10
Brussels 9
Kunming 9
Saint Petersburg 9
Shenzhen 9
Brooklyn 8
New York 8
Norwalk 8
Palaiseau 8
Turku 8
Auburn Hills 7
Falls Church 7
Fuzhou 7
Hangzhou 7
Jiaxing 7
Lanzhou 7
Taizhou 7
Lamezia Terme 6
San Diego 6
Seoul 6
Turin 6
Baghdad 5
Bangalore 5
Belo Horizonte 5
Cusco 5
Hanoi 5
Kent 5
Naples 5
Nuremberg 5
Quanzhou 5
Redondo Beach 5
San Francisco 5
Caracas 4
Chennai 4
Totale 4.909
Nome #
La cirrosi epatica 286
Usefulness of simplified acute physiology score II in predicting mortality in patients admitted to an emergency medicine ward 232
Bacterial infection in patients with advanced cirrhosis : a multicentre prospective study 205
Prognostic significance of Ki-67 labeling index after short-term presurgical tamoxifen in women with ER-positive breast cancer 202
Nadolol is superior to isosorbide mononitrate for the prevention of the first variceal bleeding in cirrhotic patients with ascites 192
Utilizzo cronico di farmaci anti-ulcera peptica/reflusso gastroesofageo e infezione batterica come causa di ricovero in soggetti anziani ricoverati in reparti di Medicina Interna 191
Humoral and cardiac effects of TIPS in cirrhotic patients with different "effective" blood volume 190
MELD score is better than Child-Pugh score in predicting 3-month survival of patietns undergoing transjugular intrahepatic portosystemic shunt 182
Trattamento endovascolare di Aneurismi dell’aorta addominale in pazienti ottantenari : risultati a medio termine [Endovascular repair of aortic abdominal aneurysms in octagenarian patients: Early and midterm results] 176
Comparison of simple tests for the non-invasive diagnosis of clinically silent cirrhosis in chronic hepatitis C 170
Clinical relevance of hyponatraemia for the hospital outcome of cirrhotic patients 170
A Prospective Italian Survey On Hepatorenal Syndrome 167
Older age increases the risk of relapse in genotype-1 chronic hepatitis C patients showing complete early virologic response during peginterferon and ribavirin therapy 167
Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites 161
Long-term administration of Isosorbide-5-mononitrate does not impair renal function in cirrhotic patients 160
A prospective survey on the treatment and survival of patients with hepatorenal syndrome 159
Study of the thrombin generation in patients with liver cirrhosis 157
Epidemiological changes of bacterial infections in cirrhotic patients: a current clinical problem 157
Artificial neural network (ANN) to predict cirrhosis in Chronic Hepatitis C (CHC). Comparison with a Logistic Regression (LG) model 156
Decline In Hemoglobin Concentration And Neutrophil Count Is Not Associated With The Likelihood Of Svr In Genotype-1 Chronic Hepatitis C Patients 154
Prevention of variceal rebleeding and treatment of liver carcinoma by consecutive transjugular intrahepatic portosystemic shunt and hepatic artery chemoembolization 153
The use of E/A ratio as a predictor of outcome in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt 151
Prevalence and incidence of cholelithiasis in patients with liver cirrhosis 150
Point-of-care coagulation monitors calibrated for the international normalized ratio for cirrhosis (INRliver) can help to implement the INRliver for the calculation of the MELD score 147
May vaptans contribute to the treatment of refractory ascites? 146
Predicting mortality risk in cirrhotic patients since the first decompensation based on a new prognostic score: the AISF-EPASCO prospective multicentre study 144
Adherence to Aasld Guidelines in the “Real World” of Hcc in Italy. Preliminary results of a prospective study 144
Patients hemoglobin decline is not associated with SVR among HCV G1-infected patients in day-to-day clinical practice 143
Diastolic dysfunction in cirrhotic patients predicts survival after TIPS 142
Diagnosis, treatment and survival of patients with hepatorenal syndrome: A survey on daily medical practice 142
Transjugular intrahepatic portosystemic shunt or paracentesis for refractory ascites - Which is best? 139
Increased flow-mediated vasodilation in cirrhotic patients with ascites : relationship with renal resistive index 137
Therapeutic strategies and emergence of multiresistant bacterial strains 137
The Systemic Inflammatory Response Syndrome (SIRS) predicts the in-hospital outcome in cirrhotic patients 136
The systemic inflammatory response syndrome in cirrhotic patients : relationship with their in-hospital outcome 136
Autonomic dysfunction : often present but usually ignored in patients with liver disease 135
Effect of intravenous tirofiban and aspirin in reducing short-term and long-term neurologic deficit in patients with ischemic stroke: A double-blind randomized trial 134
Diastolic dysfunction predicts survival in cirrhotic patients undergoing tips 132
Prevalence of bacterial resistance in cirrhotic patients with bacterial infection : a preliminary report 132
Trial for treatment of refractory ascites TIPS the scales (reply) 132
Prevention of early variceal rebleeding adding banding to terlipressin therapy 131
TIPS versus paracentesis for treatment of refractory ascites 129
Increase of left ventricular ejection fraction in advanced cirrhosis : an attempt to compensate for central hypovolemia? 127
Reduction of renal cortical blood flow assessed by doppler in cirrhotic patients with refractory ascites 126
Diastolic dysfunction is associated with poor survival in patients with cirrhosis transjugular intrahepatic portosystemic shunt 125
Low rate of mortality in patients with stage 4 cirrhosis: the need of a reassessment of an old classification. The A.I.S.F.-Epasco Prospective Multicentre Study 123
Prediction of asymptomatic cirrhosis in chronic hepatitis C patients : accuracy of artificial neural networks compared with logistic regression models 122
Increase of left ventricular ejection fraction in advanced cirrhosis : an attempt to compensate for central hypovolemia? 120
Comparison of usefulness and accuracy of simple noninvasive models as predictors of cirrhosis in chronic hepatitis C (CHC) 120
International guidelines and management of chronic hepatitis C (CHC) treatment in clinical practice 119
Pharmacological treatment of hepatorenal syndrome: a note of optimism 115
Exposure To Ribavirin But Not Hcv Genotypes Affects Response To Treatment With peginterferon And Ribavirin In Hcv Genotype 2 Or 3 104
Treatment discontinuation and dose reduction of pegylated interferon/ribavirin combination therapy in patients with chronic hepatitis C 101
Neutropenia And Infectious Complications During Combination Therapy For Chronic Hepatitis C 92
Totale 8.100
Categoria #
all - tutte 19.945
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.945


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021461 0 0 0 0 0 48 57 14 80 32 210 20
2021/2022524 29 22 10 46 16 35 77 16 55 61 50 107
2022/2023662 102 37 50 78 107 144 16 38 61 1 16 12
2023/2024399 13 33 14 10 97 38 27 26 7 29 47 58
2024/20251.293 64 118 34 132 163 34 13 145 56 143 126 265
2025/20261.081 298 98 204 133 206 142 0 0 0 0 0 0
Totale 8.100